The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)

NCT02336555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: MK-8291
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC